Belgium
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
13.05%
|
Dec. 31, 2023 | USD 20.10 | 1.93% |
|
Belgium |
|
2 |
11.14%
|
Dec. 31, 2023 | USD 193.31 | -0.57% |
|
Belgium |
|
3 |
3.44%
|
Dec. 31, 2023 | USD 23.14 | 1.75% |
|
Belgium |
|
4 |
0.24%
|
Dec. 31, 2023 | USD 13.62 | -0.32% |
|
Belgium |
|
5 |
-53.18%
|
Dec. 31, 2023 | USD 1.91 | 0.00% |
|
Belgium |
|
6 |
-1,022.08%
|
Dec. 31, 2023 | USD 10.80 | 2.86% |
|
Belgium |
|
7 |
-4,141.05%
|
Dec. 31, 2023 | USD 2.20 | -1.56% |
|
Belgium |
The Biotechnology company in Belgium with the highest EBIT Margin is Fagron NV (Brussels Stock Exchange: FAGR.BR) at 13.05%.
The Biotechnology company in Belgium with the lowest EBIT Margin is Sequana Medical NV (Brussels Stock Exchange: SEQUA.BR) at -4,141.05%.
The top 10 Biotechnology companies in Belgium by EBIT Margin are Fagron NV, UCB SA, Galapagos NV, Ion Beam Applications SA, MDxHealth SA, Nyxoah S.A. and Sequana Medical NV.
The bottom 10 Biotechnology companies in Belgium by EBIT Margin are Sequana Medical NV, Nyxoah S.A., MDxHealth SA, Ion Beam Applications SA, Galapagos NV, UCB SA and Fagron NV.